LOUISE HECKER to Humans
This is a "connection" page, showing publications LOUISE HECKER has written about Humans.
Connection Strength
0.220
-
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report. Ann Am Thorac Soc. 2024 01; 21(1):1-11.
Score: 0.022
-
Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing. Eur Respir J. 2021 11; 58(5).
Score: 0.019
-
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging. Am J Respir Cell Mol Biol. 2020 05; 62(5):633-644.
Score: 0.017
-
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis. Redox Biol. 2020 06; 33:101541.
Score: 0.017
-
Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace. Am J Physiol Lung Cell Mol Physiol. 2018 04 01; 314(4):L642-L653.
Score: 0.015
-
Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2017 Mar 01; 312(3):L297-L308.
Score: 0.014
-
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med. 2014 Apr 09; 6(231):231ra47.
Score: 0.011
-
Targeting NOX enzymes in pulmonary fibrosis. Cell Mol Life Sci. 2012 Jul; 69(14):2365-71.
Score: 0.010
-
Nonresolving fibrotic disorders: idiopathic pulmonary fibrosis as a paradigm of impaired tissue regeneration. Am J Med Sci. 2011 Jun; 341(6):431-4.
Score: 0.009
-
Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res. 2011 Aug 01; 317(13):1914-21.
Score: 0.009
-
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med. 2009 Sep; 15(9):1077-81.
Score: 0.008
-
The value of integrating policy people and space in research. J Cardiovasc Transl Res. 2009 Mar; 2(1):93-9.
Score: 0.008
-
Bioengineering functional human aortic vascular smooth-muscle strips in vitro. Biotechnol Appl Biochem. 2008 Jul; 50(Pt 3):155-63.
Score: 0.008
-
Intangible factors leading to success in research: strategy, innovation and leadership. J Cardiovasc Transl Res. 2008 Mar; 1(1):85-92.
Score: 0.007
-
Engineering the heart piece by piece: state of the art in cardiac tissue engineering. Regen Med. 2007 Mar; 2(2):125-44.
Score: 0.007
-
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension. Circulation. 2024 Jul 23; 150(4):302-316.
Score: 0.006
-
Active transcription in the vascular bed characterizes rapid progression in idiopathic pulmonary fibrosis. J Clin Invest. 2023 08 15; 133(16).
Score: 0.005
-
Contracting scars from fibrin drops. Integr Biol (Camb). 2022 03 21; 14(1):1-12.
Score: 0.005
-
Aqueous two-phase deposition and fibrinolysis of fibroblast-laden fibrin micro-scaffolds. Biofabrication. 2021 04 07; 13(3).
Score: 0.005
-
Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival. Sci Rep. 2015 Nov 24; 5:16889.
Score: 0.003
-
NADPH oxidases in lung health and disease. Antioxid Redox Signal. 2014 Jun 10; 20(17):2838-53.
Score: 0.003
-
Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest. 2013 Mar; 123(3):1096-108.
Score: 0.003
-
Histone modifications in senescence-associated resistance to apoptosis by oxidative stress. Redox Biol. 2013; 1:8-16.
Score: 0.003
-
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs. 2011 May 28; 71(8):981-1001.
Score: 0.002
-
NOX enzymes and pulmonary disease. Antioxid Redox Signal. 2009 Oct; 11(10):2505-16.
Score: 0.002
-
Getting to the heart of tissue engineering. J Cardiovasc Transl Res. 2008 Mar; 1(1):71-84.
Score: 0.002
-
Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging. 1992 May-Jun; 13(3):421-34.
Score: 0.001